Evidence map›Paper›PMID 24013726›Full record

ArticleCell death and differentiation2013

Potent and multiple regulatory actions of microglial glucocorticoid receptors during CNS inflammation.

M Á Carrillo-de Sauvage, L Maatouk, I Arnoux, M Pasco, A Sanz Diez, M Delahaye, M T Herrero, T A Newman, C F Calvo, E Audinat and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell death and differentiation, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 112 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Receptors on Microglia.Advances in neurobiology · 2024
    Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

M Á Carrillo-de Sauvage1] Department of Physiopathology of CNS diseases, Centre National de la Recherche Scientifique, UMR 7224, Molecular Genetics, Neurophysiology and Behavior Lab, Paris, France [2] Institut National de la santé et de la Recherche Médicale, UMR 952, Paris, France [3] Université Pierre et Marie Curie, Paris, France [4] Clinical and Experimental Neuroscience (NiCE-CIBERNED), School of Medicine, University of Murcia, Regional Campus of International Excellence 'Campus Mare Nostrum', Murcia, Spain.
L Maatouk
I Arnoux
M Pasco
A Sanz Diez
M Delahaye
M T Herrero
T A Newman
C F Calvo
E Audinat
F Tronche
S Vyas
Centre National de la Recherche Scientifique · FRDélégation Paris 5 · FRBiomedical Research Networking Center on Neurodegenerative Diseases · ESInserm · FRUniversity of Southampton · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In CNS, glucocorticoids (GCs) activate both GC receptor (GR) and mineralocorticoid receptor (MR), whereas GR is widely expressed, the expression of MR is restricted. However, both are present in the microglia, the resident macrophages of the brain and their activation can lead to pro- or anti-inflammatory effects. We have therefore addressed the specific functions of GR in microglia. In mice lacking GR in macrophages/microglia and in the absence of modifications in MR expression, intraparenchymal injection of lipopolysaccharide (LPS) activating Toll-like receptor 4 signaling pathway resulted in exacerbated cellular lesion, neuronal and axonal damage. Global inhibition of GR by RU486 pre-treatment revealed that microglial GR is the principal mediator preventing neuronal degeneration triggered by lipopolysaccharide (LPS) and contributes with GRs of other cell types to the protection of non-neuronal cells. In vivo and in vitro data show GR functions in microglial differentiation, proliferation and motility. Interestingly, microglial GR also abolishes the LPS-induced delayed outward rectifier currents by downregulating Kv1.3 expression known to control microglia proliferation and oxygen radical production. Analysis of GR transcriptional function revealed its powerful negative control of pro-inflammatory effectors as well as upstream inflammatory activators. Finally, we analyzed the role of GR in chronic unpredictable mild stress and aging, both known to prime or sensitize microglia in vivo. We found that microglial GR suppresses rather than mediates the deleterious effects of stress or aging on neuronal survival. Overall, the results show that microglial GR acts on several key processes limiting pro-inflammatory actions of activated microglia.

Indexed as

AnimalsCell Growth ProcessesCell MovementCentral Nervous SystemInflammationLipopolysaccharidesMiceMice, TransgenicMicrogliaNerve DegenerationNeuronsReceptors, GlucocorticoidSignal TransductionLipopolysaccharidesReceptors, Glucocorticoid

Identifiers

PMID24013726
PMCPMC3792430
OpenAlexW2050527114

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.